Last updated: January 19, 2024
Sponsor: Seoul National University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Wolman Disease
Hormone Deficiencies
Male Hormonal Deficiencies/abnormalities
Treatment
rapid ACTH stimulation test
Clinical Study ID
NCT06206655
2311-009-1480
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- patients diagnosed of liver cirrhosis
Exclusion
Exclusion Criteria:
- pregnant
- history of getting surgery of pituitary resection or adrenalectomy
- patients with diagnosis of pituitary adenoma or adrenal adenoma
- patients take steroid within 3 months
- patients take medication related to synthesis of steroid or cortisol binding proteinwithin 3 months (i.e. ketoconazole, etomidate, sex hormone, oral contraceptive)
- patients take albumin, free frozen plasma, terlipressin, glypressin within 1 month
- patients with acute medical condition
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: rapid ACTH stimulation test
Phase:
Study Start date:
December 01, 2023
Estimated Completion Date:
August 31, 2024
Connect with a study center
Seoul National University Hospital
Seoul, 03080
Korea, Republic ofActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.